The trading lower of Edwards Lifesciences' shares is directly tied to the company's recent financial performance announcement and its future earnings guidance. Such announcements are critical for investors as they adjust their expectations based on the company's projected financial health and growth prospects. The negative reaction suggests that the market may have had higher expectations than what was reported or is cautious about the company's future.